Graft-versus-host disease physical examination

Revision as of 19:14, 21 June 2017 by Shyam Patel (talk | contribs)
Jump to navigation Jump to search

Graft-versus-host disease

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Graft-versus-host disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Graft-versus-host disease physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Graft-versus-host disease physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Graft-versus-host disease physical examination

CDC on Graft-versus-host disease physical examination

Graft-versus-host disease physical examination in the news

Blogs on Graft-versus-host disease physical examination

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Graft-versus-host disease physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Overview

The physical exam for GvHD focuses on the organ involved, including the skin, liver, and GI tract. The lungs can also be involved in more rare cases.

Physical Examination

Skin

  • erythema[1]
  • maculopapular rash[1]
  • hyperpigmentation[1]
  • lichen planus-like lesions[1]
  • bullae[2]
  • desquamation[2]

Liver

  • jaundice[1]
  • pruritis[1]
  • scleral icterus[1]
  • leg swelling[1]
  • tenderness in the right upper quadrant of the abdomen[1]
  • bleeding from coagulopathy[1]
  • signs of cholestatic hepatitis[1]

GI tract

  • abdominal tenderness
  • diarrhea
  • hyperactive or hypoactive bowel sounds

Lungs

  • decreased breath sounds
  • crackles (if fluid fills the alveolar space)

Other organs

Other physical exam findings are based on the particular organ involved.

  • Eye: If there is evidence of ocular GvHD, a full ophthalmologic exam should be done.[3] Ocular GvHD can occur in up to 60% of patients, but the clinical exam findings and severity of disease is variable from patient to patient. Findings in ocular GvHD include: ocular perforation, conjunctival damage, keratopathy (corneal damage), dry eyes, loss of eyelashes. Multiple layers of the eye can be affected, including the lid, lacrimal glands, and choroid.[2] Fluorescein staining of the eye can be performed.[3]

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 Socié G, Ritz J (2014). "Current issues in chronic graft-versus-host disease". Blood. 124 (3): 374–84. doi:10.1182/blood-2014-01-514752. PMC 4102710. PMID 24914139.
  2. 2.0 2.1 2.2 Nassar A, Tabbara KF, Aljurf M (2013). "Ocular manifestations of graft-versus-host disease". Saudi J Ophthalmol. 27 (3): 215–22. doi:10.1016/j.sjopt.2013.06.007. PMC 3770225. PMID 24227989.
  3. 3.0 3.1 Herretes S, Ross DB, Duffort S, Barreras H, Yaohong T, Saeed AM; et al. (2015). "Recruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants". Invest Ophthalmol Vis Sci. 56 (4): 2348–57. doi:10.1167/iovs.14-15630. PMC 4406104. PMID 25655798.

Template:WS Template:WH